AGF US Market Neutral Anti-Beta Fund

BTAL

Market cap $303M

In the past two days, bitcoin's highest conviction holders have sold about $2.4 billion in bitcoin. Of the bitcoin sold in the past 30 days, 26% came from investors who bought it above $90,000.

Registered investment advisors did not pull back on exchange-traded funds in the first quarter of 2026. They kept adding them, according to AdvizorPro's Q1 2026 Quarterly RIA ETF Trends Report.

The AGF US Market Neutral Anti-Beta Fund ETF is downgraded from 'Buy' to 'Hold' after significant underperformance and failure to hedge in 2026. BTAL's structure remains sector-neutral, shorting high-beta stocks and going long low-beta names, but poor individual stock selection led to negative -13.9% returns this year. Despite correct macro positioning, BTAL's active management failed to deliver intended negative beta exposure or effective downside protection in 2026.

For years, the standard 60/40 portfolio relied on a simple inverse relationship between equities and bonds. However, as volatility spikes, that safety net is fraying, and panelists at Exchange discussed responses to this challenge.

Commodity and defensive ETFs surged as Iran war tensions rattled markets, pushing several funds close to one-month highs.

AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL) excels as a tactical hedge, not a traditional buy-and-hold investment. BTAL monetizes the spread between low and high beta stocks, thriving in risk-off or overextended market environments. The ETF is delta-neutral by sector, reducing portfolio volatility and drawdowns, and improves Sharpe ratio when paired with equities.

When high-beta stocks stumble and markets turn volatile, AGFiQ U.S. Market Neutral Anti-Beta Fund ( NYSEARCA:BTAL ) is designed to deliver.

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is long in 200 low-beta stocks and short in 200 high-beta stocks. BTAL has value characteristics and low company risk, but its track record is uncompelling, with negative return since 2011. FTLS stands out as a superior long-short ETF alternative for investors seeking risk-adjusted performance.

BTAL offers a market-neutral strategy by going long low-beta and short high-beta U.S. stocks, providing S&P 500 hedging. The ETF plays the low vs. high beta spread, offering stronger short-term hedging and better long-term preservation than classic shorts. In my view, it must be included in a portfolio with a clear strategy; otherwise, it's dead weight, not added value.

AGF U.S. Market Neutral Anti-Beta Fund ETF is designed as a market-neutral equity hedge, long low-beta and short high-beta stocks, to benefit investors during market corrections. Despite its intent, the Fund has underperformed benchmarks and is best used only during significant market declines, not as a long-term core holding. Given current market conditions, I recommend a 'Sell' rating on BTAL. Despite my negative sentiment, BTAL could benefit from economic uncertainty and geopolitical risks.